Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flecainide: a new prototype antiarrhythmic agent.

J M Nappi, J L Anderson

    Pharmacotherapy
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Flecainide acetate, a Class IC antiarrhythmic, effectively treats various arrhythmias by prolonging conduction with minimal repolarization effects. It is generally well-tolerated and suitable for convenient twice-daily dosing.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mind the gap: decreasing disparities in care for transgender patients.

    Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors·2025
    Same author

    Evaluation of the effects of water quality on drinking preferences of heifer calves.

    JDS communications·2022
    Same author

    Effects of yeast culture supplementation on lactation performance and rumen fermentation profile and microbial abundance in mid-lactation Holstein dairy cows.

    Journal of dairy science·2021
    Same author

    Effects of peripartal yeast culture supplementation on lactation performance, blood biomarkers, rumen fermentation, and rumen bacteria species in dairy cows.

    Journal of dairy science·2021
    Same author

    Symposium review: Strategies to improve the efficiency and profitability of heifer raising.

    Journal of dairy science·2020
    Same author

    Symposium review: Colostrum management and calf nutrition for profitable and sustainable dairy farms.

    Journal of dairy science·2019
    Same journal

    Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

    Pharmacotherapy·2026
    Same journal

    Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

    Pharmacotherapy·2026
    Same journal

    The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

    Pharmacotherapy·2026
    Same journal

    Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

    Pharmacotherapy·2026
    Same journal

    Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

    Pharmacotherapy·2026
    Same journal

    Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

    Pharmacotherapy·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology

    Background:

    • Flecainide acetate is a Class IC antiarrhythmic agent.
    • It was the first of its class marketed in the United States.

    Purpose of the Study:

    • To review the pharmacological properties, efficacy, and safety of flecainide acetate.
    • To assess its potential for widespread clinical use.

    Main Methods:

    • Review of in vitro, animal, and human studies.
    • Analysis of efficacy trials and adverse effect data.
    • Examination of pharmacokinetic data including excretion and half-life.

    Main Results:

    • Flecainide acetate markedly prolongs conduction with minimal effect on repolarization.
    • It is effective for a wide range of ventricular and selected atrial arrhythmias.

    Related Experiment Videos

  • Generally well-tolerated with minor, dose-responsive central nervous system side effects; potential for proarrhythmic effects exists.

    • Conclusions:

    • Flecainide acetate demonstrates significant efficacy in treating various arrhythmias.
    • Its pharmacokinetic profile supports convenient dosing regimens.
    • The drug has potential for widespread use in managing cardiac arrhythmias.